Management of pulmonary embolus in pregnancy

European Heart Journal

Volumn 20, Issue 19, 1999, Pages 1378-1385

  De Swiet, M ^a  

^a QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

Author keywords

Heparin; Low molecular weight heparin; Pregnancy; Pregnancy complications; Pulmonary embolus; Warfarin

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ARTERIAL GAS; BLOOD CLOT LYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LUNG EMBOLISM; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; THROMBOPHILIA; VENA CAVA FILTER;

ANTICOAGULANTS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS; PULMONARY EMBOLISM; RISK FACTORS; THROMBOLYTIC THERAPY; VENA CAVA FILTERS;

EID: 0032868702     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1584     Document Type: Review

References (56)

1. Koonin LM, Atrash HK, Lawson HW, Smith JC. Maternal mortality surveillance, United States, 1979-1986. MMWR CDC Suveill Summ 1991; 40 (SS-2): 1-13.
2. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1994-96. HMSO, 1998.
3. British Thoracic Society Standards of Care Committee. Thorax 1997; 52 (Suppl 4): S1-24.
4. NIH 1986. Prevention of venous thrombosis and pulmonary embolism. NIH Consensus Development. JAMA 1986; 256: 744-9.
5. Clarke-Pearson DL, Jelovsek FR. Alterations of occlusive cuff impedance plethysmography results in the obstetric patient. Surgery 1981; 89: 594-8.
6. Macklon NS, Greer IA, Bowman AW. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol 1997; 104: 191-7.
7. Macklon NS, Greer IA. The deep venous system in the puerperium: an ultrasound study. Br J Obstet Gynaecol 1997; 104: 198-200.
8. Bonnar J. Haemostasis and coagulation disorders in pregnancy. In: Bloom AL, Thomas DP, eds. Haemostasis and thrombosis, 2nd edn. Edinburgh, Scotland: Churchill Livingstone, 1987: 570-84.
9. Weiner CP, Kwaan H, Hauck WW, Duboe FJ, Paul M, Wallemark CB. Fibrin generation in normal pregnancy. Obstet Gynecol 1984; 64: 46-8.
10. de Swiet M. Thromboembolism. In: de Swiet M, ed. Medical disorders in obstetric practice, 3rd edn. Oxford: Blackwell Scientific Publications, 1995: 116-42.
11. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation 1996; 93: 2212-45.
12. Peek MJ, Nelson-Piercy C, Manning RA, de Swiet M, Letsky EA. Activated protein C resistance in normal pregnancy. Br J Obstet Gynaecol 1997; 104: 1084-6.
13. Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood 1986; 68: 881-5.
14. de Swiet M, Fidler J, Howell R, Letsky E. Thromboembolism in pregnancy. In: Jewell D, ed. Advanced Medicine. London: Pitman Medical, 1981: 80: 309-17.
15. Rutherford S, Montoro M, McGehee W, Strong T. Thromboembolic disease associated with pregnancy: an 11 year review. Am J Obstet Gynecol 1991; 164 (Suppl): 286.
16. Macklon NS, Greer IA. Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scott Med J 1996; 41: 83-6.
17. Ginsberg JS, Brill-Edwards P, Burrows RF et al. Venous thrombosis during pregnancy: leg and trimester of presentation. Thromb Haemost 1992; 67: 519-20.
18. Report on Confidential Enquiries into Maternal Deaths in England and Wales 1973-5. Department of Health and Social Security. London: HMSO, 1979.
19. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1988-90. Department of Health. London: HMSO, 1994.
20. Carr MH, Towers CV, Eastenson AR, Pircon RA, Iriye BK, Adashek JA. Prolonged bedrest during pregnancy: does the risk of deep vein thrombosis warrant the use of routine heparin prophylaxis? J Matern Fetal Med 1997; 6: 264-7.
21. Hirsch DR, Mikkola KM, Marks PW et al. Pulmonary embolism and deep vein thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden. Am Heart J 1996; 131: 1145-8.
22. Friedreich PW et al. Frequency of pregnancy related venous thromboembolism in anticoagulant factor deficient women: implications for prophylaxis. Ann Int Med 1996; 125: 955-60.
23. Carson JL, Kelley MA, Duff A et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326: 1240-5.
24. Ginsberg JS, Hirsh J, Rainbow AJ, Coates G. Risks to the fetus of radiologie procedures used in the diagnosis of maternal venous thromboembolic disease. Thromb Haemost 1989; 61: 189-96.
25. Ang CK, Tan TH, Walters WA, Wood C. Postural influence on maternal capillary oxygen and carbon dioxide tension. BMJ 1969; 4: 201-3.
26. Toglia MR, Weg JG. Venous Thromboembolism during Pregnancy. N Engl J Med 1996; 335: 108-14.
27. Miniati M, Pistolesi M, Marini C et al. Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISA-PED). Am J Respir Crit Care Med 1996; 154: 1387-93.
28. Spritizer CE, Evans AC, Kay HH. Magnetic resonance imaging of deep venous thrombosis in pregnant women with lower extremity edema. Obstet Gynecol 1995; 85: 603-7.
29. Wells PS, Anderson DR, Bormanis J, Guy F, Mitchell M, Lewandowski B. SimpliRED D-Dimer can reduce the diagnostic tests in suspected deep vein thrombosis. Lancet 1998; 351: 1405-6.
30. Savage P, Roddie M, Seckl. A 28-year-old woman with pulmonary embolus. Lancet 1998; 352: 30-1.
31. Omri A, Delaloye JF, Andersen H, Bachmann F. Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy. Thromb Haemost 1989; 61: 55-6.
32. Ginsberg JS, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 1995; 108 (Suppl): 305S-311S.
33. Ginsberg JS, Hirsh J, Turner DC, Levine MN, Burrows R. Risks to the fetus of anticoagulant therapy during pregnancy. Thromb Haemost 1989; 61: 197-203.
34. Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980; 68: 122-40.
35. Wong V, Cheng CH, Chan KC. Fetal and neonatal outcome of exposure to anticoagulants during pregnancy. Am J Med Genet 1993; 45: 17-21.
36. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. Circulation 1996; 93: 2212-45.
37. Dahlman T, Lindvall N, Hellgren M. Osteopenia in pregnancy during long-term heparin treatment: a radiological study post partum. Br J Obstet Gynaecol 1990; 97: 221-8.
38. Ojukwu C, Jenkinson SD, Obeid D. Deep vein thrombosis in pregnancy and heparin hypersensitivity. Br J Obstet Gynaecol 1996; 103: 934-6.
39. Nelson Piercy C, Letsky EA, de Swiet M. Low molecular weight heparin for obstetric thromboprophyllaxis: experience of 69 pregnancies in 61 women at high risk. Am J Obstet Gynecol 1997; 176: 1062-8.
40. Dahlman TC, Hellgren MS, Blomback M. Thrombosis prophylaxis in pregnancy with use of subcutaneous heparin adjusted by monitoring heparin concentration in plasma. Am J Obstet Gynecol 1989; 161: 420-5.
41. Orme ML, Lewis PJ, de Swiet M et al. May mothers given warfarin breast-feed their infants? BMJ 1997; 1: 1564-5.
42. Turrentine MA, Braems G, Ramirez MM. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet Gynecol Surv 1995; 50: 534-41.
43. Goldhaber SZ, Haire WD, Feldstein ML et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993; 341: 507-11.
44. Greenfield J, Proctor MC. Role of catheter embolectomy in treating pulmonary embolism Semin. Resp Crit Care Med 1996; 17: 71-85.
45. Greenfield LJ, Cho KJ, Proctor MC, Sobel M, Shah S, Wingo J. Late results of suprarenal Greenfield vena cava filter placement. Arch Surg 1992; 127: 969-73.
46. Chuu WM, Wang NY, Perry D. Vena caval filters for the prevention of pulmonary embolism. N Engl J Med 1998; 339: 46-8.
47. Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 1998; 338: 409-15.
48. Tan J, de Swiet M. Use of aspirin for obstetric thromboprophylaxis in low risk women. J Obs Gynaecol 1998; 18 (Suppl 1): S46-7.
49. Baddarraco MA, Vessey MP. Recurrence of venous thromboembolic disease and use of oral contraceptives. Br Med J 1974; 1: 215-7.
50. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - 111: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Br Med J 1994; 308: 235-46.
51. CLASP Collaborative Group. (Writing Committee Redman CWG, de Swiet M, Collins M & Grant A). A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619-29.
52. Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task. Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy. J Clin Pathol 1993; 46: 489-96.
53. Girling J, de Swiet M. Inherited thrombophilia and pregnancy. Curr Opin Obstet Gynaecol 1998; 10: 135-44.
54. Conard J, Horellou MH, Van Dreden P, Lecompte T, Samama M. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thromb Haemost 1990; 63: 319-20.
55. Hough RE, Makris M, Preston FE. Pregnancy in women with thrombophilia: incidence of thrombosis and pregnancy outcome (Abstr). Br J Haem 1996; 93 (Suppl 2): 136.
56. Papinger I, Schneider B. Thrombotic risk in ereditary Anti-thrombin III, Protein C, or protein S deficiency. A cooperative retrospective study. Study Group on Natural Inhibitors. Arterioscler Thromb Vasc Biol 1996; 16: 742-8.